论文部分内容阅读
2015年9月,在股市上,达拉匹林一夜药价暴涨55倍,整个美国都震惊了。这个事件的主角马丁·谢科雷利(Martin Shkreli)是图灵制药公司的首席执行官,原来是一家对冲基金公司经理,他宣布在他的运作下,已有62年历史的抗寄生虫老药的价格从每片13.50美元猛涨至750美元,对此,没有几个人支持他、恭喜他令人惊异的敏锐商业才能。相反地,来自四面八方的人们都对他表示了鄙视:药厂CEO、美国总统的竞选者、社会媒体评论者、专栏作家和期刊编辑,所有人都把谢科雷利描绘成最坏的强盗药物大亨。据一家非常热心的媒体称,他已经“官方”地变成了美国最痛恨的人。
In September 2015, on the stock market, the price of daltaparin overnight jumped 55-fold and the entire United States was shocked. Martin Shkreli, the chief executive of Turing Pharmaceuticals, the protagonist of the event, formerly a hedge fund manager, announced that under his operation, 62-year-old antiparasitic With prices soaring from $ 13.50 per tablet to $ 750, few supported him and congratulated him on his astounding business acumen. On the contrary, people from all walks of life have expressed contempt for him: CEOs of pharmaceutical companies, presidential candidates for the United States, commentators for social media, columnists and periodical editors, all portraying Shcherreli as the worst bandit drug Tycoon. According to a very enthusiastic media, he has become “the most official hated” person in the United States.